Rihanna Spotted Heading to César Restaurant in Paris After Céline Dion Concert
By Rodrigo Santos Andrade
Big pharma racing to hedge patent expiry
visibility comment0 event October 5, 2026 timer 16:04
Pharma firms closed biopharma buyouts worth over a hundred billion dollars in the first half of the year, racing to replace top selling medicines worth around $400 billion before patents expire. Leah Bennett of Concurrent explains.
Channel: Reuters
Tags: Big Pharma, Biotech Innovation, Drug Patents, Drug Pipeline Diversification, Generic Competition, Patent Cliff, Patent Expiry, Pharmaceutical Industry, Pharmaceutical M&A, Pharmaceutical Strategy, Revenue Hedging
No Comments
